3166 related articles for article (PubMed ID: 6280832)
1. Breast cancer skin test antigens of increased sensitivity prepared from vesicular stomatitis virus-infected tumor cells.
Austin FC; Boone CW; Levin DL; Cavins JA; Djerassi I; Rosner D; Case R; Klein E
Cancer; 1982 May; 49(10):2034-42. PubMed ID: 6280832
[TBL] [Abstract][Full Text] [Related]
2. Melanoma skin test antigens of improved sensitivity prepared from vesicular stomatitis virus-infected tumor cells.
Boone CW; Austin FC; Gail M; Case R; Klein E
Cancer; 1978 May; 41(5):1781-7. PubMed ID: 77181
[TBL] [Abstract][Full Text] [Related]
3. Serological response of melanoma patients to vaccines prepared from VSV lysates of autologous and allogeneic cultured melanoma cells.
Livingston PO; Albino AP; Chung TJ; Real FX; Houghton AN; Oettgen HF; Old LJ
Cancer; 1985 Feb; 55(4):713-20. PubMed ID: 2981601
[TBL] [Abstract][Full Text] [Related]
4. Analysis of soluble melanoma cell membrane antigens in metastatic cells of various organs and further studies of antigens present in primary melanoma.
Hollinshead AC
Cancer; 1975 Oct; 36(4):1282-8. PubMed ID: 51680
[TBL] [Abstract][Full Text] [Related]
5. Human cell surface proteins selectively assembled into vesicular stomatitis virus virions.
Závada J; Závadová Z; Russ G; Poláková K; Rajcáni J; Stencl J; Loksa J
Virology; 1983 Jun; 127(2):345-60. PubMed ID: 6306914
[TBL] [Abstract][Full Text] [Related]
6. Identity of HeLa cell determinants acquired by vesicular stomatitis virus with a tumor antigen.
Little LM; Zavada J; Der CJ; Huang AS
Science; 1983 Jun; 220(4601):1069-71. PubMed ID: 6302845
[TBL] [Abstract][Full Text] [Related]
7. Vesicular stomatitis virus-infected L1210 murine leukemia cells: increased immunogenicity and altered surface antigens.
Wise KS
J Natl Cancer Inst; 1977 Jan; 58(1):83-90. PubMed ID: 189042
[TBL] [Abstract][Full Text] [Related]
8. Localization of T helper cell epitopes in the vesicular stomatitis virus: the nucleoprotein is responsible for serotype cross-reactive T help.
Burkhart C; Freer G; Steinhoff U; Li Y; Bishop DH; Zinkernagel RM; Hengartner H
Viral Immunol; 1994; 7(3):103-11. PubMed ID: 7541205
[TBL] [Abstract][Full Text] [Related]
9. Pseudotypes of vesicular stomatitis virus with coat antigen of bovine leukaemia virus--VSV (BLV): antigenic surface mosaic and the roles of precipitating antibodies and polycations.
Závadová Z; Závada J
Acta Virol; 1980 May; 24(3):166-74. PubMed ID: 6158852
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte migration inhibition by soluble extracts of MCF-7 tissue culture cell line derived from breast carcinoma.
McCoy JL; Jerome LF; Anderson C; Cannon GB; Alford TC; Connor RJ; Oldham RK; Herberman RB
J Natl Cancer Inst; 1976 Nov; 57(5):1045-9. PubMed ID: 1003541
[TBL] [Abstract][Full Text] [Related]
11. Further characterization of proteins assembled by vesicular stomatitis virus from human tumor cells.
Závada J; Huang AS
Virology; 1984 Oct; 138(1):16-25. PubMed ID: 6093357
[TBL] [Abstract][Full Text] [Related]
12. Immunoprecipitating human antigens associated with vesicular stomatitis virus grown in HeLa cells.
Little LM; Lanman G; Huang AS
Virology; 1983 Aug; 129(1):127-36. PubMed ID: 6310874
[TBL] [Abstract][Full Text] [Related]
13. Delayed cutaneous hypersensitivity reactions to extracts of breast cancer and melanoma tissue in cancer patients.
Fossati G; Canevari S; Pierotti MA; Vezzoni P; Porta GD; Vaglini M
J Natl Cancer Inst; 1979 Jun; 62(6):1381-5. PubMed ID: 286110
[No Abstract] [Full Text] [Related]
14. Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells.
Sheil JM; Bevan MJ; Lefrancois L
J Immunol; 1987 Jun; 138(11):3654-60. PubMed ID: 3035010
[TBL] [Abstract][Full Text] [Related]
15. VSV pseudotype produced in cell line derived from human mammary carcinoma.
Závada J; Zázadová Z; Malír A; Koćent A
Nat New Biol; 1972 Nov; 240(99):124-5. PubMed ID: 4345004
[No Abstract] [Full Text] [Related]
16. Interactions of vesicular stomatitis virus with murine cell surface antigens.
Hecht TT; Summers DF
J Virol; 1976 Sep; 19(3):833-45. PubMed ID: 61285
[TBL] [Abstract][Full Text] [Related]
17. Antigen processing of vesicular stomatitis virus in situ. Interdigitating dendritic cells present viral antigens independent of marginal dendritic cells but fail to prime CD4(+) and CD8(+) T cells.
Ciavarra RP; Greene AR; Horeth DR; Buhrer K; van Rooijen N; Tedeschi B
Immunology; 2000 Dec; 101(4):512-20. PubMed ID: 11122455
[TBL] [Abstract][Full Text] [Related]
18. The production of vesicular stomatitis virus by antigen- or mitogen-stimulated lymphocytes and continuous lymphoblastoid lines.
Nowakowski M; Feldman JD; Kano S; Bloom BR
J Exp Med; 1973 Apr; 137(4):1042-59. PubMed ID: 4348276
[TBL] [Abstract][Full Text] [Related]
19. Vesicular stomatitis virus pseudotype with neutralization antigen of tick-borne encephalitis virus.
Dragúnová J; Greśíková M
Acta Virol; 1986 Jul; 30(4):346-8. PubMed ID: 2876617
[TBL] [Abstract][Full Text] [Related]
20. Presence of a mouse mammary tumor virus-related antigen in human breast carcinoma cells and its absence from normal mammary epithelial cells.
Yang NS; McGrath CM; Furmanski P
J Natl Cancer Inst; 1978 Nov; 61(5):1205-8. PubMed ID: 81881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
